Lataa...
Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma
To identify risk factors for infection in patients with diffuse large B cell lymphoma (DLBCL) undergoing rituximab, cyclophosphamide, vincristine, adriamycin and prednisolone (R-CHOP) treatment. All patients with DLBCL who received R-CHOP from 2004–2014 in a tertiary Australian hospital were identif...
Tallennettuna:
| Julkaisussa: | Sci Rep |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5493675/ https://ncbi.nlm.nih.gov/pubmed/28667319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-04495-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|